T. Crosby - Concepedia

Author

T. Crosby

Also Known As

A Cowie, Clarence Bolt, T Crosby, T D L Crosby, T. Crosby, T. D. Crosby, T. D. L. Crosby, T.D. Crosby, T.D.L Crosby, T.D.L. Crosby

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Velindre Cancer Centre Cardiff University University of Oxford Velindre NHS Trust Royal Surrey County Hospital

About

T. Crosby is an author at Velindre Cancer Centre specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	575
2	Health Sciences	9	9	404
3	Gastroenterology	7	7	244
4	Cell Biology	1	1	10
5	Immunology	1	1	10

T. Crosby

Publications

Citations

H-Index

Page 1

	Year	Citations
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial T. Crosby, Stephen Falk, Simon Gollins, The Lancet Oncology	2013	378
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial David Cunningham, Sally Stenning, Elizabeth Smyth, The Lancet Oncology	2017	282
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) Brian O’Neill, S M Griffin, C. Mariette, BMC Cancer	2017	156
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial John V. Reynolds, Shaun R. Preston, Brian Patrick O’Neill, The Lancet. Gastroenterology & hepatology	2023	155
Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452). John V. Reynolds, Shaun R. Preston, Brian O’Neill, Journal of Clinical Oncology Surgical OncologyEsophageal CancerCancer ManagementGastroenterologySurgery	2021	113
Definitive chemoradiation in patients with inoperable oesophageal carcinoma T. Crosby, A. Brewster, Annabel Borley, British Journal of Cancer	2004	103
Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1 Samantha Cox, Ceri Powell, Ben Carter, British Journal of Cancer	2016	98
Study to Determine Adequate Margins in Radiotherapy Planning for Esophageal Carcinoma by Detailing Patterns of Recurrence After Definitive Chemoradiotherapy M. Button, Carys Morgan, Elizabeth Croydon, International Journal of Radiation OncologyBiologyPhysics Esophageal CancerHealth SciencesRadiation TherapyMedicineEsophageal Carcinoma	2008	82
Small cell oesophageal carcinoma: an institutional experience and review of the literature Emma Hudson, J. Powell, Saptarshi Mukherjee, British Journal of Cancer Surgical OncologyEsophageal CancerPathologySurgeryRadical Radiotherapy	2007	64
The Significance of Cardiac Doses Received During Chemoradiation of Oesophageal and Gastro–oesophageal Junctional Cancers Saptarshi Mukherjee, D Aston, M Minett, Clinical Oncology Cardiac Doses ReceivedSurgical OncologyEsophageal CancerRadiation TherapyGastrointestinal Oncology	2003	46

Page 1